Ofev 100 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9HJ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,095
Award facts
- Contract value 100% obligated
- $9,094.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of OFEV (pirfenidone) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $9,094.99 and an ultimate completion date of January 20, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains on a global basis. This specific delivery order for OFEV, an antifibrotic medication used in the treatment of idiopathic pulmonary fibrosis, reflects the breadth of specialized medications distributed through the DLA's medical supply chain to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9HJ0?
SPE2DR26F9HJ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26F9HJ0 worth?
The government has obligated $9,095 on SPE2DR26F9HJ0.
Is contract SPE2DR26F9HJ0 an order under another contract?
Yes. SPE2DR26F9HJ0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HJ0 competed?
The extent of competition for SPE2DR26F9HJ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award